__
PWRM, Power3 Medical Products Inc., PWRM.OB
PWRM is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer�s disease, Parkinson�s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig�s disease).
PWRM applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, PWRM has developed a portfolio of products including BC-SeraPro�, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro�, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer�s, Parkinson�s and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual�s proteins to detect the presence of disease, a patient�s disease progression, a patient�s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators. PWRM works with key physician scientists at major medical research and treatment centers. With access to decisive human clinical samples and superior trade secret proteomic methodologies, PWRM provides solutions to pressing challenges in diagnosis and treatment of patients and has concluded research agreements, technology license agreements, and filed provisional and utility patents.
Alzheimer’s doesn’t have any immediate cure, but remedies for indicators can be found and investigate carries on. Even though current Alzheimer treatment options cannot cease Alzheimer’s disease from progressing, they’re able to temporarily decrease the speed of the deterioration involving signs of illness in addition to advance quality of life for the people with Alzheimer’s disease as well as all their caregivers. Today, there exists a international exertion under approach to finding better ways to take care of the condition, postponement its onset, and prevent it from escalating.
Soon after skin cancer, cancer of the breast is easily the most widespread cancers recognized in females in the united states. But breast cancer rates now have fallen in recent times, even so medical professionals are not certain the key reason why. Even now, for numerous women of all ages, breast cancer could be the condition they will fear most
Parkinson’s disease is really a problem that affects nerve cells, or neurons, inside of a section of the brain of which controls muscle motions. In Parkinson’s, nerves which make an important chemical called dopamine die or do not work properly. Dopamine generally delivers impulses that assist synchronize a person’s activities.
More about PWRM at www.Power3Medical.com
United States Steel Corp. (NYSE:X) recently reported several appointments in its North American operations unit effective Jan. 1, 2011. Scott H. Coleman has been named general manager of Great Lakes Works, U. S. Steel’s integrated steelmaking facility in Ecorse and River Rouge, Mich. Anton Jura, who currently serves as general manager � Canadian operations for the company’s U. S. Steel Canada subsidiary, will advance to the role of president and general manager of U. S. Steel Canada.
United States Steel Corporation, through its subsidiaries, engages in the production and sale of steel products primarily in North America and Europe.
Stryker Corp. (NYSE:SYK) recently reported an increase in the size of its Board of Directors to ten and the election of Allan C. Golston as a director, effective January 1, 2011. Mr. Golston has served since 2006 as President, United States Program for the Bill & Melinda Gates Foundation and is a director for Malt-O-Meal, a privately held breakfast cereal corporation. Mr. Golston has previously been a Chief Financial and Administrative Officer for the Bill & Melinda Gates Foundation and Director, Finance for Swedish Health Services. Mr. Golston holds a master’s degree in business from Seattle University. He also is a Certified Public Accountant.
Stryker is one of the world’s leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care.
Colgate-Palmolive Co. (NYSE:CL) recently reported that Stephen C. Patrick, its Chief Financial Officer will be succeeded by Dennis Hickey, currently Vice President and Corporate Controller effective January 1, 2011. Mr. Patrick will assume the role of Vice Chairman until his retirement in March 2011.
Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition.
No comments:
Post a Comment